SCS Stock Chart & Stats
zł0.42
--
Market closed
zł0.42
--
Day’s Range― - ―
52-Week Rangezł0.28 - zł0.54
Previous CloseN/A
VolumeN/A
Average Volume (3M)3.53K
Market Cap
zł21.70M
Enterprise ValueN/A
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta-0.26
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding41,336,500
10 Day Avg. Volume6,427
30 Day Avg. Volume3,530
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SCS FAQ
What was Stem Cells Spin SA’s price range in the past 12 months?
Stem Cells Spin SA lowest stock price was zł0.28 and its highest was zł0.54 in the past 12 months.
What is Stem Cells Spin SA’s market cap?
Stem Cells Spin SA’s market cap is zł21.70M.
When is Stem Cells Spin SA’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Stem Cells Spin SA’s earnings last quarter?
Currently, no data Available
Is Stem Cells Spin SA overvalued?
According to Wall Street analysts Stem Cells Spin SA’s price is currently Overvalued.
Does Stem Cells Spin SA pay dividends?
Stem Cells Spin SA does not currently pay dividends.
What is Stem Cells Spin SA’s EPS estimate?
Stem Cells Spin SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Stem Cells Spin SA have?
Stem Cells Spin SA has 41,336,500 shares outstanding.
What happened to Stem Cells Spin SA’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Stem Cells Spin SA?
Currently, no hedge funds are holding shares in PL:SCS
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Technical Analysis
Biomaxima SA
―
Biomed-Lublin Wytwornia Surowic i Szczepionek S.A.
―
OncoArendi Therapeutics SA
―
Mabion SA
―
Medicofarma Biotech Spolka Akcyjna
―